These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32654955)

  • 1. Circulating markers of oxidative stress are associated with a muscle injury in patients with muscular dystrophy Duchenne.
    Almeida-Becerril T; Rodríguez-Cruz M; Raúl Sánchez-González J; Antonio Villaldama-Soriano M; Atilano-Miguel S; Villa-Morales J; Cárdenas-Conejo A; Cárdenas-Vázquez R
    Brain Dev; 2021 Jan; 43(1):111-120. PubMed ID: 32654955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress in Duchenne muscular dystrophy: focus on the NRF2 redox pathway.
    Petrillo S; Pelosi L; Piemonte F; Travaglini L; Forcina L; Catteruccia M; Petrini S; Verardo M; D'Amico A; Musarò A; Bertini E
    Hum Mol Genet; 2017 Jul; 26(14):2781-2790. PubMed ID: 28472288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophy.
    Terrill JR; Al-Mshhdani BA; Duong MN; Wingate CD; Abbas Z; Baustista AP; Bettis AK; Balog-Alvarez CJ; Kornegay JN; Nghiem PP; Grounds MD; Arthur PG
    PLoS One; 2020; 15(10):e0240317. PubMed ID: 33031394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of circulating miRNAs in Duchenne disease: Association with muscle injury and metabolic parameters.
    Almeida-Becerril T; Rodríguez-Cruz M; Hernández-Cruz SY; Ruiz-Cruz ED; Mendoza CRS; Cárdenas-Conejo A; Escobar-Cedillo RE; Ávila-Moreno F; Aquino-Jarquin G
    Acta Neurol Scand; 2022 Nov; 146(5):512-524. PubMed ID: 36000352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Nrf2, Glutathione, and Malondialdehyde Correlate with Disease Severity in Duchenne Muscular Dystrophy.
    Almeida-Becerril T; Rodríguez-Cruz M; Villa-Morales J; Sánchez-Mendoza CR; Galeazzi-Aguilar JE
    Antioxidants (Basel); 2023 Apr; 12(4):. PubMed ID: 37107246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy.
    Terrill JR; Duong MN; Turner R; Le Guiner C; Boyatzis A; Kettle AJ; Grounds MD; Arthur PG
    Redox Biol; 2016 Oct; 9():276-286. PubMed ID: 27611888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy.
    Hu J; Kong M; Ye Y; Hong S; Cheng L; Jiang L
    J Neurochem; 2014 Jun; 129(5):877-83. PubMed ID: 24460924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of oxidative stress and aging in Duchene muscular dystrophy patients and the possible ameliorating effect of He:Ne laser.
    Abdel SE; Abdel-Meguid I; Korraa S
    Acta Myol; 2007 Jul; 26(1):14-21. PubMed ID: 17915565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoprostanes in dystrophinopathy: Evidence of increased oxidative stress.
    Grosso S; Perrone S; Longini M; Bruno C; Minetti C; Gazzolo D; Balestri P; Buonocore G
    Brain Dev; 2008 Jun; 30(6):391-5. PubMed ID: 18180123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age.
    Messina S; Vita GL; Aguennouz M; Sframeli M; Romeo S; Rodolico C; Vita G
    Acta Myol; 2011 Jun; 30(1):16-23. PubMed ID: 21842588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural History of Serum Enzyme Levels in Duchenne Muscular Dystrophy and Implications for Clinical Practice.
    Rodríguez-Cruz M; Almeida-Becerril T; Atilano-Miguel S; Cárdenas-Conejo A; Bernabe-García M
    Am J Phys Med Rehabil; 2020 Dec; 99(12):1121-1128. PubMed ID: 32520799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Inflammation in Duchenne Muscular Dystrophy: Association with Muscle Function and Nutritional Status.
    Cruz-Guzmán Odel R; Rodríguez-Cruz M; Escobar Cedillo RE
    Biomed Res Int; 2015; 2015():891972. PubMed ID: 26380303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Correlation of Skeletal and Cardiac Muscle Dysfunction in Duchenne Muscular Dystrophy.
    Posner AD; Soslow JH; Burnette WB; Bian A; Shintani A; Sawyer DB; Markham LW
    J Neuromuscul Dis; 2016; 3(1):91-99. PubMed ID: 27182492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The muscle regeneration marker FOXP3 is associated with muscle injury in Duchenne muscular dystrophy.
    Yannin Hernández-de la Cruz S; Ordaz-Robles T; Antonio Villaldama-Soriano M; Emmanuel Luna-Guzmán C; Almeida-Becerril T; Villa-Morales J; Cárdenas-Conejo A; Dolores Ruíz-Cruz E; Maldonado-Hernandez J; Bernabe-Garcia M; Barbosa-Cortés L; Rodríguez-Cruz M
    Brain Dev; 2024 May; 46(5):199-206. PubMed ID: 38388302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic thiol/disulphide homeostasis in children with Duchenne muscular dystrophy.
    Incecik F; Avcıoğlu G; Erel Ö; Neşelioğlu S; Hergüner OM
    Acta Neurol Belg; 2019 Jun; 119(2):215-218. PubMed ID: 30607902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free intramuscular Mg
    Reyngoudt H; Lopez Kolkovsky AL; Carlier PG
    NMR Biomed; 2019 Sep; 32(9):e4115. PubMed ID: 31184793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series.
    Senesac CR; Lott DJ; Forbes SC; Mathur S; Arpan I; Senesac ES; Walter GA; Vandenborne K
    Phys Ther; 2015 Jul; 95(7):978-88. PubMed ID: 25592189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
    Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy.
    Mathur S; Lott DJ; Senesac C; Germain SA; Vohra RS; Sweeney HL; Walter GA; Vandenborne K
    Arch Phys Med Rehabil; 2010 Jul; 91(7):1051-8. PubMed ID: 20599043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.